Stay updated on Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page
- ChecktodayChange DetectedRevision: v3.3.4 has been added to the record history, replacing the previous v3.3.3 entry, a minor metadata update that does not affect study data, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page history shows a new revision v3.3.2 was added and the previous v3.3.1 removed, reflecting a minor update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.3.1 appears in the page footer, replacing v3.2.0. This is a minor version update and does not affect study information or page functionality.SummaryDifference0.0%

- Check58 days agoChange DetectedThe banner about government funding/operating status in the page header was removed.SummaryDifference0.3%

- Check73 days agoChange DetectedThe record history shows multiple updates to the study status, recruitment status, and contacts/locations across several versions. These changes reflect ongoing progress and adjustments to site availability and contact information.SummaryDifference0.0%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.